He received board certifications in Radiotherapy (2001) and Medical Oncology (2004). He worked there on predictive assays for EGFR-targeted therapies in lung cancer, including immunohistochemistry, gene copy number, and activating mutations. His fellowships were funded by the International Union Against Cancer and the International Association for the Study of Lung Cancer. He then returned to his home institution to serve as a deputy chair of the department.